Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

Acinetobacter baumannii has become a major concern for scientific attention due to
extensive antimicrobial resistance. This resistance causes an increase in mortality rate …

Infections caused by Acinetobacter baumannii (AB), an increasingly prevalent nosocomial
pathogen, have been associated with high morbidity and mortality. We conducted this study …

Acinetobacter baumannii is increasingly associated with various epidemics, representing a
serious concern due to the broad level of antimicrobial resistance and clinical …

Background Acinetobacter baumannii is an emerging bacterial pathogen that causes a
broad array of infections, particularly in hospitalized patients. Many studies have focused on …

Antibiotic resistance is one of the biggest challenges for the clinical sector and industry,
environment and societal development. One of the most important pathogens responsible …

Acinetobacter baumannii infections have become an emerging health concern in hospitals
across the world and are often associated with nosocomial infections with poorer clinical …

Acinetobacter baumannii is one of the most challenging nosocomial pathogens due to the
emergence and widespread of antibiotic resistance. We aimed to provide the first analysis of …

Acinetobacter baumannii is a Gram-negative, glucose-non-fermenting, oxidase-negative
coccobacillus, most commonly associated with the hospital settings. The ability to survive in …

To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and
define individual risk factors for MDR, we used epidemiologic methods, performed organism …